CAR T-Cell Immunotherapy has been named Advance of the Year in Annual ASCO Report. Cancer experts looking back over the past 12 months have highlighted adoptive immunotherapy with chimeric antigen receptor (CAR) T cells as the…
Communication between patients and research study staff can be challenging if both parties have different cultural and linguistic backgrounds. Specialized applications can potentially alleviate these problems and significantly contribute to an effective, improved care process when…
We participated and exhibited in three conferences this year – DIA, DPharm and AMIA. An awesome experience as always, our featured product this year was a no code DIY research study app making platform – called Appbakery….
We are excited to announce that last month our online patient-recruitment platform iConnect 2.0 went live with CenterWatch. Clinical trials professionals as well as patients trust CenterWatch to get any information related to clinical trials. It…
Two radically new gene based immunotherapies were approved by the FDA this year – Kymriah followed by Yescarta – in August and October, respectively. Approved in August 2017, before Novartis named the drug Kymriah (Tisagenlecleucel) – it…
The rapid technological evolution of smartphone and sensory devices over the last few years are significantly improving the sophistication of mobile apps, and are expanding the range and potential of ePROs (Electronic patient reported outcomes). Some…
TrialX is excited to participate and present in AMIA 2017, the 41st anniversary of the annual symposia conducted by the American Medical Informatics Association (AMIA). Every year, leading informaticians such as – translational scientists, clinicians,…
